Company news: Elixinol Global; Bod Australia; MGC Pharma; Cronos Australia; Epsilon Healthcare by Martin Lane April 23, 2021April 29, 2021 Elixinol Global Elixinol Global has reported revenue of A$2.3 million for the March quarter, down 26% […]
Industry reacts to TGA down-scheduling decision with cautious optimism by Martin Lane December 17, 2020December 17, 2020
Elixinol Global bullish after positive Q3 results by Martin Lane September 22, 2020September 22, 2020
Low-dose CBD down scheduling is good news for consumers and the industry: Elixinol CEO by Josie Tutty August 5, 2020August 5, 2020
Covid blamed for revenue slide as Elixinol switches focus to high-margin branded product by Steve Jones August 3, 2020August 4, 2020
Your daily dose of cannabis news: Hemp market set to soar; THC Global’s director support; Elixinol’s Aussie foothold; MGC Pharma’s promising results by Martin Lane July 28, 2020July 28, 2020
